Thank you, Madam Chair.
Thank you for inviting me to appear before you today.
The difficulty in bridging the gap between science and the market is not new. It has been hampering Canada’s competitiveness for more than two decades.
Canada has a solid technological and scientific base. Our universities are among the best in the world. Our researchers are internationally recognized, and several sectors—from aerospace to artificial intelligence to life sciences—demonstrate remarkable expertise. Our publicly funded basic research is an essential pillar of this ecosystem. It fuels discoveries, trains talent and creates the foundation for value-creating innovation, but this potential remains underexploited.
The data confirms the extent of this gap. As the world’s ninth-largest economy, Canada has only 24 companies among the 2,000 most innovative companies on the planet, according to the European Innovation Scoreboard 2024, published by the European Union. France has 50, and South Korea has 83.
In the recently released Global Innovation Index 2025, Canada has fallen from 14th to 17th place out of the 139 countries evaluated, mainly due to a decline in its output ranking.
Private investment in research and development, or R and D, accounts for 1.07% of gross domestic product, or GDP, compared to an average of 2% among Organisation for Economic Co-operation and Development, or OECD, countries. South Korea, cited as a model of science-industry integration, devotes nearly 5% of its GDP to R and D. What is important is that 79% of the investment comes from the private sector. In Canada, it is just under 55%. Small and medium-sized enterprises, or SMEs, which make up 98% of our economic fabric, account for 60% of employment, but only 30% of private R and D spending.
The tax incentive program for scientific research and experimental development was amended in 2024 and again yesterday in the 2025 budget statement. This should help to increase the share of private investment in R and D.
Beyond the financial aspect, companies, and particularly SMEs, need two other components to translate discoveries and inventions into concrete applications that will find a place in the market. The first is support for experimental development. The second is access to a pool of talent and expertise trained in applied research and technology transfer.
The first component concerns support during the phase when research becomes a prototype, a proof of concept, a product or a validated process.
In Europe, this link is filled by organizations such as “research and technology organizations”, or RTOs. These non-profit structures combine infrastructure, knowledge and skills. Their mandate is precisely to translate knowledge into transferable prototypes and patents. The European Association of Research and Technology Organisations, EARTO, which brings together more than 350 RTOs, has shown that they play an essential role in attracting private funding for innovation by sharing the risks of experimental development and linking public research to the needs of businesses.
Canada must take inspiration from this and support this transitional R and D. Initiatives and organizations exist across Canada. We have some in Quebec. Canada would benefit from structuring and supporting a Canada-wide applied research network based on RTO models, capable of working with universities, colleges and businesses, especially SMEs, at every stage of technological development.
The second component concerns talent. According to the Conference Board of Canada, access to a skilled workforce directly influences investment decisions. Businesses invest more in R and D when they can also count on talent trained in interface skills, such as R and D project management, technology transfer or commercialization.
Universities have a key role to play in promoting internships in companies and training in such interface skills.
For university researchers, it is difficult to combine publication goals and the need for rapid results from companies, in addition to intellectual property barriers. Canada could explore models that support applied research and the recognition of hybrid career paths.
The German Fraunhofer model offers a response to these obstacles. More than 75 institutes led by university professors are jointly funded by the government and industry. Fraunhofer researchers and their teams, including master’s and doctoral students, often work on the premises of partner companies. This proximity creates a shared culture of innovation, where applied research, training and commercialization reinforce each other. According to assessments by the German Ministry of Research, every euro invested in these institutes generates more than three euros in economic benefits.
Furthermore, in a context of skilled labour shortages, a study by the Centre for Interuniversity Research and Analysis on Organizations, CIRANO, has shown that, in order to promote the adoption of artificial intelligence, for example, it is also important to focus on skills development in the workplace through mentoring and learning approaches in applied research projects, among other things. These initiatives help strengthen the innovation capacity of businesses. Such programs can be implemented with universities or within the framework of RTOs, which offer an environment conducive to knowledge transfer and practical training for both trainees and business staff.
In conclusion, to bridge the gap between science and the market and increase private investment in R and D, Canada should strengthen support for experimental development, structure and support a Canada-wide network of applied research inspired by RTOs, and invest in partnership-based research talent and knowledge transfer.
Thank you for your attention, Madam Chair.